ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Columbus, OH, USA:

Epcoritamab and Rituximab for First-line Follicular Lymphoma

of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma...

Active, not recruiting
Low Grade Non-Hodgkin's Lymphoma, Adult
Follicular Lymphoma
Drug: Rituximab
Drug: Epcoritamab

Phase 2

Reid Merryman, MD

Columbus, Ohio, United States and 3 other locations

and ibrutinib in patients with previously treated mantle cell lymphoma to evaluate the efficacy of this combination, with the primary object...

Active, not recruiting
B Cell Lymphoma
Mantle Cell Lymphoma
Drug: Ibrutinib
Drug: Palbociclib

Phase 2

Alliance Foundation Trials

Columbus, Ohio, United States and 8 other locations

DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) may be able to join ...

Active, not recruiting
Lymphoma, Malignant
Non-hodgkin Lymphoma
Drug: DS-3201b

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Columbus, Ohio, United States and 20 other locations

Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy

Phase 3

Novartis
Novartis

Columbus, Ohio, United States and 66 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Columbus, Ohio, United States and 31 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Columbus, Ohio, United States and 71 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Columbus, Ohio, United States and 215 other locations

chimeric antigen receptor (CAR) T cell therapy for non-Hodgkins lymphoma and in whom have had a sub-optimal response early on to CAR T-cell ...

Enrolling
B-Cell Non-Hodgkin Lymphoma-Recurrent
Primary Mediastinal Large B-Cell Lymphoma-Refractory
Procedure: Biopsy
Procedure: Computed Tomography

Phase 1

Nathan Denlinger

Columbus, Ohio, United States

with obinutuzumab in treating patients with B-cell non-Hodgkin lymphoma that has returned after a period of improvement or not responding to...

Active, not recruiting
Refractory Burkitt Lymphoma
Recurrent Burkitt Lymphoma
Drug: Venetoclax
Drug: Lenalidomide

Phase 1

Beth Christian

Columbus, Ohio, United States and 1 other location

hydrochloride in treating patients with recurrent non-Hodgkin lymphoma (NHL). BTK inhibitor PCI-32765 may stop the growth of cancer cells by...

Active, not recruiting
Recurrent Grade 1 Follicular Lymphoma
Recurrent Mantle Cell Lymphoma
Drug: bendamustine hydrochloride
Other: pharmacogenomic studies

Phase 1

Kami Maddocks, MD

Columbus, Ohio, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems